Rapid virological response tailors the duration of treatment in hepatitis C virus genotype 3 patients treated with pegylated interferon alfa-2a and ribavirin.

Slides:



Advertisements
Similar presentations
Epidemiological trends and the effect of airport fever screening on prevention of domestic dengue fever outbreaks in Taiwan, 1998–2007 Mei-Mei Kuan, Ting.
Advertisements

Development of a foundation for a case definition of post-treatment Lyme disease syndrome John N. Aucott, Lauren A. Crowder, Kathleen B. Kortte International.
High frequency variations of Helicobacter pylori isolates in individual hosts in a Chinese population L. Ren, Y.L. Liao, Y. Song, Y. Guo, X.H. Mao, Q.H.
Robert Koch and the ‘golden age’ of bacteriology Steve M. Blevins, Michael S. Bronze International Journal of Infectious Diseases Volume 14, Issue 9, Pages.
Syndromic classification of rickettsioses: an approach for clinical practice Álvaro A. Faccini-Martínez, Lara García-Álvarez, Marylin Hidalgo, José A.
Hepatitis C virus core protein induces hepatic metabolism disorders through down- regulation of the SIRT1–AMPK signaling pathway Jian-Wu Yu, Li-Jie Sun,
Infective endocarditis caused by Streptococcus bovis complicated by a superior mesenteric artery mycotic aneurysm and systemic septic emboli in a patient.
Early impact of pneumococcal conjugate vaccine on invasive pneumococcal disease in Singapore children, 2005 through 2010  Koh Cheng Thoon, Chia Yin Chong,
Efficacy and Safety of Ledipasvir/Sofosbuvir with and without Ribavirin in Patients with Chronic Hepatitis C Virus Genotype 1 Infection: a meta-analysis 
The potential of social networks for early warning nad outbreak detection systems: the swine flu Twitter study  P. Kostkova, E. de Quincey, G. Jawaheer 
Classification of virologic responses based on outcomes during and after a 48-week course of pegylated interferon (PEG IFN) plus ribavirin antiviral therapy.
Increasing trend of syphilis and infection resistance: a retrospective study  Jinping Gao, Jinhua Xu, Yujun Sheng, Xiaoguang Zhang, Change Zhang, Yang.
Yang Luo, Guo-Ping He, Jijan-Wei Zhou, Ying Luo 
Risk factors and prevalence of tuberculosis, human immunodeficiency virus, syphilis, hepatitis B virus, and hepatitis C virus among prisoners in Pakistan 
L.S. Chathuranga, F. Noordeen, A.M.S.B. Abeykoon 
Adjunctive therapy with interferon-gamma for the treatment of pulmonary tuberculosis: a systematic review  X.-F. Gao, Z.-W. Yang, J. Li  International.
Hepatitis B immunoglobulin injection in pregnancy to interrupt hepatitis B virus mother- to-child transmission—a meta-analysis  Zhongjie Shi, Xiaomao Li,
Antonio Cascio, Chiara Iaria, Paolo Ruggeri, Walter Fries 
HCV mono-infected and HIV/HCV co-infected individuals treated with direct-acting antivirals: to what extent do they differ?  Giuseppe Bruno, Annalisa.
Neonatal tetanus elimination in Pakistan: progress and challenges
Classification of virologic responses based on outcomes during and after a 48-week course of pegylated interferon (PEG IFN) plus ribavirin antiviral therapy.
Volume 149, Issue 6, Pages (November 2015)
Which patients with genotype 1 chronic hepatitis C can benefit from prolonged treatment with the ‘accordion’ regimen?  Patrick Marcellin, E. Jenny Heathcote,
Yellow fever vaccination status and safety in hemodialysis patients
The diagnostic and prognostic significance of SCUBE1 levels in Crimean-Congo hemorrhagic fever  Ahmet Menteşe, Gürdal Yilmaz, Ayşegül Sümer, Mustafa Arslan,
Effect of climate variables on dengue incidence in a tropical Caribbean municipality of Colombia, Cerete, 2003–2008  Salim Mattar, Victor Morales, Alexander.
Effect of oral ribavirin treatment on the viral load and disease progression in Crimean- Congo hemorrhagic fever  Hürrem Bodur, Ayşe Erbay, Esragül Akıncı,
Systematic review of hepatocellular carcinoma mortality rates among hepatitis B virus- infected renal transplant recipients, with supplemental analyses.
Odontogenic maxillofacial space infections at a tertiary care center in North India: a five- year retrospective study  George C. Mathew, Laxman Kumar Ranganathan,
Borrelia burgdorferi infection and Lyme disease in children
Volume 139, Issue 4, Pages (October 2010)
Feifei Mao, Jianhua Wu, Huiyu Sun, Qisheng You, Dan Li 
Comparison of two strategies to prevent varicella outbreaks in housing facilities for asylum seekers  Serge de Valliere, Naim Cani, Maya Grossenbacher,
Management of Patients Coinfected With HCV and HIV: A Close Look at the Role for Direct-Acting Antivirals  Susanna Naggie, Mark S. Sulkowski  Gastroenterology 
Pure red cell aplasia following pegylated interferon α treatment
Volume 149, Issue 6, Pages (November 2015)
S. J. Hullegie, J. E. Arends, B. J. A. Rijnders, W. L. Irving, D
Volume 139, Issue 4, Pages (October 2010)
Virological tools to diagnose and monitor hepatitis C virus infection
Peginterferon alfa-2b plus ribavirin for chronic hepatitis
Improved Virologic Response in Chronic Hepatitis C Genotype 4 Treated With Nitazoxanide, Peginterferon, and Ribavirin  Jean–François Rossignol, Asem Elfert,
Volume 149, Issue 4, Pages e1 (October 2015)
Dibbendhu Khanra, Arunansu Talukdar 
Michael Biermer, Thomas Berg  Gastroenterology 
Value in Health Regional Issues
Integrated Care Increases Treatment and Improves Outcomes of Patients With Chronic Hepatitis C Virus Infection and Psychiatric Illness or Substance Abuse 
Volume 155, Issue 5, Pages e2 (November 2018)
Volume 141, Issue 5, Pages (November 2011)
Analysis of intracellular human immunodeficiency virus (HIV)-1 drug resistance mutations in multi-failed HIV-1-infected patients treated with a salvage.
Treatment of hepatitis C
Modifications of haematological series in patients co-infected with human immunodeficiency virus and hepatitis C virus during treatment with interferon.
Acute hepatitis C: Current status and remaining challenges
New HCV therapies on the horizon
Onur Baser, MS, PhD, Akif Altinbas, MD, Erdem Baser, MS, M
Hepatitis C virus and interferon type III (interferon-λ3/interleukin-28B and interferon-λ4): genetic basis of susceptibility to infection and response.
Development and specificities of anti-interferon neutralizing antibodies in patients with chronic hepatitis C treated with pegylated interferon-α  C.
Volume 139, Issue 4, Pages e4 (October 2010)
Volume 144, Issue 7, Pages e2 (June 2013)
Rafael Esteban, Maria Buti  Gastroenterology 
Volume 145, Issue 4, Pages e3 (October 2013)
Dynamics of hepatitis B virus quasispecies heterogeneity in association with nucleos(t)ide analogue treatment determined by MALDI-TOF MS  M. Rybicka,
Volume 139, Issue 6, Pages (December 2010)
Alessio Aghemo, Maria Francesca Donato  Gastroenterology 
Hepatitis C treatment in patients with kidney disease
Christos Konstantakis, Maria Karamesini, Christos Triantos 
Volume 147, Issue 2, Pages e1 (August 2014)
Volume 147, Issue 6, Pages (December 2014)
New patterns of HIV-1 resistance during HAART
The Results of Phase III Clinical Trials With Telaprevir and Boceprevir Presented at the Liver Meeting 2010: A New Standard of Care for Hepatitis C Virus.
Induction Pegylated Interferon Alfa-2b in Combination With Ribavirin in Patients With Genotypes 1 and 4 Chronic Hepatitis C: A Prospective, Randomized,
Presentation transcript:

Rapid virological response tailors the duration of treatment in hepatitis C virus genotype 3 patients treated with pegylated interferon alfa-2a and ribavirin in Pakistan  Uzma Gill, Hafsa Aziz, Muzaffar Lateef Gill  International Journal of Infectious Diseases  Volume 17, Issue 11, Pages e1017-e1021 (November 2013) DOI: 10.1016/j.ijid.2013.05.012 Copyright © 2013 International Society for Infectious Diseases Terms and Conditions

Figure 1 Flow diagram of patient enrollment, and disposition of patients treated with PEG IFN alfa-2a. International Journal of Infectious Diseases 2013 17, e1017-e1021DOI: (10.1016/j.ijid.2013.05.012) Copyright © 2013 International Society for Infectious Diseases Terms and Conditions

Figure 2 Predictability of SVR in the 16-week and 24-week treatment groups with RVR. International Journal of Infectious Diseases 2013 17, e1017-e1021DOI: (10.1016/j.ijid.2013.05.012) Copyright © 2013 International Society for Infectious Diseases Terms and Conditions

Figure 3 Predictability of SVR in the 24-week treatment group without RVR. International Journal of Infectious Diseases 2013 17, e1017-e1021DOI: (10.1016/j.ijid.2013.05.012) Copyright © 2013 International Society for Infectious Diseases Terms and Conditions

Figure 4 Multiple logistic regression model to predict SVR. International Journal of Infectious Diseases 2013 17, e1017-e1021DOI: (10.1016/j.ijid.2013.05.012) Copyright © 2013 International Society for Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.